PHARMARESEARCH BIO Co., Ltd. (XKON:217950)
South Korea
· Delayed Price · Currency is KRW
37,200
-1,800 (-4.62%)
At close: Aug 14, 2025, 3:30 PM KST
PHARMARESEARCH BIO Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2014 | FY 2014 |
| Dec '14 Dec 31, 2014 | Mar '14 Mar 31, 2014 |
| Revenue | 178.19 | 321.18 |
| Revenue Growth (YoY) | -44.52% | - |
| Cost of Revenue | 16.83 | 18.41 |
| Gross Profit | 161.36 | 302.77 |
| Selling, General & Admin | 823.15 | 430.09 |
| Research & Development | 83.03 | 71.44 |
| Other Operating Expenses | 10.23 | 9.45 |
| Operating Expenses | 921.11 | 514.16 |
| Operating Income | -759.75 | -211.4 |
| Interest Expense | -122.85 | -38.8 |
| Interest & Investment Income | 0.99 | 0.01 |
| Currency Exchange Gain (Loss) | - | 0.19 |
| Other Non Operating Income (Expenses) | -1.9 | 4.58 |
| EBT Excluding Unusual Items | -883.52 | -245.41 |
| Asset Writedown | - | -1 |
| Pretax Income | -883.52 | -246.41 |
| Net Income | -883.52 | -246.41 |
| Net Income to Common | -883.52 | -246.41 |
| Shares Outstanding (Basic) | 0 | 0 |
| Shares Outstanding (Diluted) | 0 | 0 |
| Shares Change (YoY) | -0.00% | - |
| EPS (Basic) | -22088.06 | -6160.12 |
| EPS (Diluted) | -22088.06 | -6160.12 |
| Free Cash Flow | -415.75 | -251.99 |
| Free Cash Flow Per Share | -10393.76 | -6299.54 |
| Gross Margin | 90.55% | 94.27% |
| Operating Margin | -426.37% | -65.82% |
| Profit Margin | -495.83% | -76.72% |
| Free Cash Flow Margin | -233.32% | -78.46% |
| EBITDA | -755.07 | -208.21 |
| EBITDA Margin | - | -64.83% |
| D&A For EBITDA | 4.69 | 3.19 |
| EBIT | -759.75 | -211.4 |
| EBIT Margin | - | -65.82% |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.